Numbers didn't add up for Maitec

Numbers didn't add up for Maitec

Knowing when to quit is as important as knowing when to forge ahead. The Liposome Co. Inc., which has a full plate of development projects, last week said it suspended development of Maitec, its liposomal gentamicin product, after looking at the economics of the drug. LIPO now plans to seek a partner for Maitec...